Table 1 Profile of BSE listed companies operating on the pharmaceutical market
Company name | Key features in 2019 |
|---|---|
Antibiotice SA | - holds the leading position in the segment of generic and OTC medicines sold in hospitals and ranks 20th in the overall pharmaceutical market (market share of 1.89%); - is a world leader in the production of the active substance Nystatin; - has majority state capital (over 53%); - exports accounted for 40% of turnover with medicines produced successful in America, Europe and Asia. |
Medlife SA | - is one of the largest private medical service companies in Central and Eastern Europe, also being present in the pharmaceutical business, managing 10 pharmacies operating their own clinics; - the market share of the pharmaceutical market is insignificant; - has majority Romanian private capital and is mainly owned by Romanian individuals. |
Ropharma | - an important chain of pharmacies that ranks 4th among the top of pharmacy chains operating on the Romanian market with a market share exceeding 7%; - has majority foreign private capital and is mainly owned by foreign legal entities. |
Farmaceutica Remedia | - an important chain of pharmacies in Romania with its activities focused on integrated business services such as imports, sales, wholesale distribution, logistics services, marketing, drug registration for major pharmaceutical manufacturers; - its market share of the pharmaceutical market is estimated at less than 3%; - has majority private Romanian capital and is mainly owned by Romanian individuals; |
Biofarm SA | - one of the most important producers of medicines and food supplements in Romania, operating mainly on the OTC market; - ranks third on the Romanian pharmaceutical market in terms of turnover; - has majority private Romanian capital and is mainly owned by financial investment companies; - exports represent less than 3% of turnover with products being marketed in 12 countries in Europe and Asia. |
Zentiva | - one of the most important drug manufacturers in Romania with production units in Romania and the Czech Republic and ranking second in drug sales on the Romanian market; - has mostly foreign private capital, is part of the Zentiva Group, and is mainly owned by foreign legal entities; - exports represented over 40% of turnover. Until 2018, exports were managed by a company within the Sanofi group. |